Lenvatinib Impurity 31 | CAS 417714-14-8 - Request Quote
Lenvatinib Impurity 31
| SZ CAT No: | SZ-L038052 |
| CAS No | 417714-14-8 |
| Mol.F. | C21H20N4O4 |
| Mol.Wt. | 392.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Lenvatinib Impurity 31 is chemically 4-(4-(3-Cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamide. Lenvatinib Impurity 31 is supplied with detailed characterization data compliant with regulatory guideline. Lenvatinib Impurity 31 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lenvatinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 417714-14-8
Purchase 417714-14-8
Order 417714-14-8
Enquire 417714-14-8
price of 417714-14-8
417714-14-8 Supplier
417714-14-8 Manufacturer
417714-14-8 Exporter
buy high quality Lenvatinib Impurity 31
Purchase Lenvatinib Impurity 31
Lenvatinib Impurity 31 suppliers
Lenvatinib Impurity 31 manufacturers
Lenvatinib Impurity 31 price
Order Lenvatinib Impurity 31
Enquire Lenvatinib Impurity 31
Lenvatinib Impurity 31 cost
Lenvatinib Impurity 31 Supplier
Lenvatinib Impurity 31 Distributor
Lenvatinib Impurity 31 for Method Validation
Lenvatinib Reference Standard
Lenvatinib Impurity 31 for ANDA Filing
Lenvatinib Impurity 31 for Forced Degradation Studies
Lenvatinib Impurity 31 Identification Standards
Lenvatinib Impurity 31 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.